This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsutsumida, H. Articles by Hollingsworth, M. A. Search for Related Content PubMed PubMed Citation Articles by Tsutsumida, H. Articles by Hollingsworth, M. A.

RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer Cells

Authors' Affiliations: ¹ Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; ² Division of Surgical Pathology, Kagoshima University Hospital; and ³ Department of Human Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

Requests for reprints: Michael A. Hollingsworth, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805. Phone: 402-559-8343; Fax: 402-559-4651; E-mail: mahollin{at}unmc.edu.

MUC1 is a highly glycosylated, type I transmembrane protein expressed by normal ductal epithelial cells of the pancreas, breast, lung, and gastrointestinal tract, and overexpressed in many cases of adenocarcinoma. We down-regulated MUC1 expression by RNA interference and investigated the effects on malignant and metastatic potential of a human pancreatic cancer cell line, S2-013. MUC1-suppressed clones, S2-013.MTII.C1 and S2-013.MTII.C2, were established by targeting a sequence 3,151 bp from the initiation codon and characterized in vitro for proliferation, invasion, and adhesion. We evaluated the effects of MUC1 suppression in vivo on tumor growth and metastatic properties following implantation into the cecum or pancreas of athymic mice. MUC1-suppressed clones showed significantly decreased proliferation in vitro and in vivo. Global gene expression was evaluated by oligonucleotide microarray analysis. Surprisingly, genes predicted to increase doubling times (cyclin B1 and cyclin D3) were overexpressed in MUC1-suppressed clones. There were alterations in expression of several genes that may affect the malignant properties of pancreatic cancer. Adhesion of MUC1-suppressed cells in vitro to type IV collagen and fibronectin was slightly increased, and adhesion was slightly decreased to type I collagen and laminin. Results of implantation to cecum and pancreas showed significant reduction of metastasis to lymph nodes, lung, or peritoneal sites compared with S2-013.gfp-neo control cells. These results support the hypothesis that MUC1 contributes significantly to growth and metastasis, and that down-regulation of MUC1 protein expression decreases the metastatic potential of pancreatic adenocarcinoma.

This article has been cited by other articles:

				J. M. Bailey, B. J. Swanson, T. Hamada, J. P. Eggers, P. K. Singh, T. Caffery, M. M. Ouellette, and M. A. Hollingsworth Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer Clin. Cancer Res., October 1, 2008; 14(19): 5995 - 6004. [Abstract] [Full Text] [PDF]

				M.-K. Shyu, M.-C. Lin, C.-H. Liu, Y.-R. Fu, J.-C. Shih, C.-N. Lee, H.-Y. Chen, J. Huang, M.-C. Huang, and F.-J. Hsieh MUC1 Expression Is Increased During Human Placental Development and Suppresses Trophoblast-Like Cell Invasion In Vitro Biol Reprod, August 1, 2008; 79(2): 233 - 239. [Abstract] [Full Text] [PDF]

				I. K Gipson, T. Blalock, A. Tisdale, S. Spurr-Michaud, S. Allcorn, A. Stavreus-Evers, and K. Gemzell MUC16 Is Lost from the Uterodome (Pinopode) Surface of the Receptive Human Endometrium: In Vitro Evidence That MUC16 Is a Barrier to Trophoblast Adherence Biol Reprod, January 1, 2008; 78(1): 134 - 142. [Abstract] [Full Text] [PDF]

				D. V. Gold, Z. Karanjawala, D. E. Modrak, D. M. Goldenberg, and R. H. Hruban PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma Clin. Cancer Res., December 15, 2007; 13(24): 7380 - 7387. [Abstract] [Full Text] [PDF]

				T. D. Blalock, S. J. Spurr-Michaud, A. S. Tisdale, S. R. Heimer, M. S. Gilmore, V. Ramesh, and I. K. Gipson Functions of MUC16 in Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4509 - 4518. [Abstract] [Full Text] [PDF]

				P. L. Beatty, S. E. Plevy, A. R. Sepulveda, and O. J. Finn Cutting Edge: Transgenic Expression of Human MUC1 in IL-10-/- Mice Accelerates Inflammatory Bowel Disease and Progression to Colon Cancer J. Immunol., July 15, 2007; 179(2): 735 - 739. [Abstract] [Full Text] [PDF]

				P. K. Singh, Y. Wen, B. J. Swanson, K. Shanmugam, A. Kazlauskas, R. L. Cerny, S. J. Gendler, and M. A. Hollingsworth Platelet-Derived Growth Factor Receptor {beta}-Mediated Phosphorylation of MUC1 Enhances Invasiveness in Pancreatic Adenocarcinoma Cells Cancer Res., June 1, 2007; 67(11): 5201 - 5210. [Abstract] [Full Text] [PDF]